- Home
- GERN vs WTTR Comparison
GERN vs WTTR Comparison
Compare GERN & WTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- WTTR
- Stock Information
- Founded
- GERN 1990
- WTTR 2016
- Country
- GERN United States
- WTTR United States
- Employees
- GERN 229
- WTTR N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- WTTR Oilfield Services/Equipment
- Sector
- GERN Health Care
- WTTR Energy
- Exchange
- GERN Nasdaq
- WTTR Nasdaq
- Market Cap
- GERN 823.0M
- WTTR 922.1M
- IPO Year
- GERN 1996
- WTTR 2017
- Fundamental
- Price
- GERN $1.30
- WTTR $9.02
- Analyst Decision
- GERN Buy
- WTTR Strong Buy
- Analyst Count
- GERN 8
- WTTR 3
- Target Price
- GERN $3.71
- WTTR $15.00
- AVG Volume (30 Days)
- GERN 6.6M
- WTTR 984.5K
- Earning Date
- GERN 11-06-2025
- WTTR 11-04-2025
- Dividend Yield
- GERN N/A
- WTTR 3.08%
- EPS Growth
- GERN N/A
- WTTR N/A
- EPS
- GERN N/A
- WTTR 0.32
- Revenue
- GERN $164,447,000.00
- WTTR $1,458,995,000.00
- Revenue This Year
- GERN $175.15
- WTTR N/A
- Revenue Next Year
- GERN $56.61
- WTTR $0.71
- P/E Ratio
- GERN N/A
- WTTR $28.18
- Revenue Growth
- GERN 11877.20
- WTTR N/A
- 52 Week Low
- GERN $1.09
- WTTR $7.20
- 52 Week High
- GERN $4.83
- WTTR $15.14
- Technical
- Relative Strength Index (RSI)
- GERN 42.28
- WTTR 58.10
- Support Level
- GERN $1.27
- WTTR $8.23
- Resistance Level
- GERN $1.52
- WTTR $8.73
- Average True Range (ATR)
- GERN 0.06
- WTTR 0.31
- MACD
- GERN -0.02
- WTTR 0.11
- Stochastic Oscillator
- GERN 8.00
- WTTR 77.78
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.